• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性带状疱疹(HZ)的临床和免疫学特征。

Clinical and immunologic features of recurrent herpes zoster (HZ).

机构信息

Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan.

Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan.

出版信息

J Am Acad Dermatol. 2016 Nov;75(5):950-956.e1. doi: 10.1016/j.jaad.2016.05.037. Epub 2016 Jul 26.

DOI:10.1016/j.jaad.2016.05.037
PMID:27473453
Abstract

BACKGROUND

Recurrent herpes zoster (HZ) is thought to be rare, but there have been few large-scale studies of recurrent HZ.

OBJECTIVE

We conducted a large-scale prospective cohort study to characterize recurrent HZ.

METHODS

We examined 12,522 participants aged 50 years or older in Shozu County and followed them up for 3 years. We compared the incidence of HZ and postherpetic neuralgia, severity of skin lesions and acute pain, cell-mediated immunity, and varicella-zoster virus-specific antibody titer between primary and recurrent HZ.

RESULTS

A total of 401 participants developed HZ: 341 with primary HZ and 60 with recurrent HZ. Skin lesions and acute pain were significantly milder and the incidence of postherpetic neuralgia was lower in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ. Varicella-zoster virus skin test induced a stronger reaction in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ.

LIMITATIONS

Information on previous HZ episodes was self-reported by participants, so it could not be confirmed that they actually had a history of HZ.

CONCLUSION

Recurrent HZ was associated with milder clinical symptoms than primary HZ, probably because of stronger varicella-zoster virus-specific cell-mediated immunity in the patients with recurrence.

摘要

背景

复发性带状疱疹(HZ)被认为很少见,但鲜有关于复发性 HZ 的大规模研究。

目的

我们进行了一项大规模的前瞻性队列研究,以明确复发性 HZ 的特征。

方法

我们对 Shozu 县的 12522 名 50 岁及以上的参与者进行了检查,并对其随访了 3 年。我们比较了原发性和复发性 HZ 患者的 HZ 和带状疱疹后神经痛发生率、皮损和急性疼痛严重程度、细胞介导免疫以及水痘-带状疱疹病毒特异性抗体滴度。

结果

共有 401 名参与者发生 HZ:341 名原发性 HZ 和 60 名复发性 HZ。50 至 79 岁复发性 HZ 患者的皮损和急性疼痛明显较轻,带状疱疹后神经痛发生率低于原发性 HZ 患者。50 至 79 岁复发性 HZ 患者的水痘-带状疱疹病毒皮肤试验反应强于原发性 HZ 患者。

局限性

既往 HZ 发作的信息由参与者自行报告,因此不能确认他们实际上有 HZ 病史。

结论

复发性 HZ 的临床症状较原发性 HZ 轻,可能是因为复发性 HZ 患者的水痘-带状疱疹病毒特异性细胞介导免疫更强。

相似文献

1
Clinical and immunologic features of recurrent herpes zoster (HZ).复发性带状疱疹(HZ)的临床和免疫学特征。
J Am Acad Dermatol. 2016 Nov;75(5):950-956.e1. doi: 10.1016/j.jaad.2016.05.037. Epub 2016 Jul 26.
2
VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia.水痘带状疱疹病毒皮肤试验反应而非抗体,是带状疱疹后神经痛的一个重要预测因素。
J Dermatol Sci. 2015 Sep;79(3):235-40. doi: 10.1016/j.jdermsci.2015.05.011. Epub 2015 Jun 1.
3
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.水痘带状疱疹病毒皮肤试验反应与疱疹后皮肤症状和带状疱疹相关疼痛的严重程度呈负相关,但抗体则不是。
J Dermatol Sci. 2013 Mar;69(3):243-9. doi: 10.1016/j.jdermsci.2012.10.015. Epub 2012 Nov 5.
4
VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study.水痘带状疱疹病毒特异性细胞介导免疫与带状疱疹的发生率及皮肤症状和带状疱疹相关疼痛的严重程度呈负相关,但与体液免疫无关:SHEZ 研究。
Vaccine. 2019 Oct 16;37(44):6776-6781. doi: 10.1016/j.vaccine.2019.09.031. Epub 2019 Sep 19.
5
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.基于社区前瞻性队列研究的日本50岁及以上成年人带状疱疹和带状疱疹后神经痛的发病率:SHEZ研究
J Epidemiol. 2015;25(10):617-25. doi: 10.2188/jea.JE20140210. Epub 2015 Sep 19.
6
Vaccination: a new option to reduce the burden of herpes zoster.接种疫苗:减轻带状疱疹负担的新选择。
Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32.
7
Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.德国≥50 岁成年人中带状疱疹和带状疱疹后神经痛的发生率和成本:一项前瞻性研究。
J Infect. 2018 May;76(5):475-482. doi: 10.1016/j.jinf.2018.02.001. Epub 2018 Feb 8.
8
Herpes zoster and postherpetic neuralgia.带状疱疹和带状疱疹后神经痛。
Expert Rev Vaccines. 2010 Mar;9(3 Suppl):21-6. doi: 10.1586/erv.10.30.
9
The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study.速肤带状疱疹(SHEZ)研究:一项前瞻性队列研究的原理、设计和描述。
J Epidemiol. 2012;22(2):167-74. doi: 10.2188/jea.je20110035. Epub 2012 Feb 18.
10
Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.日本60岁及以上成年人带状疱疹和带状疱疹后神经痛的负担:一项基于医生实践的观察性前瞻性队列研究的结果。
J Dermatol. 2017 Apr;44(4):414-422. doi: 10.1111/1346-8138.13639. Epub 2016 Dec 5.

引用本文的文献

1
An Atypical Presentation of Post-herpetic Neuralgia and Bell's Palsy in a Diabetic Patient: A Case Report.一名糖尿病患者的带状疱疹后神经痛和贝尔麻痹的非典型表现:病例报告
Cureus. 2025 Apr 25;17(4):e83014. doi: 10.7759/cureus.83014. eCollection 2025 Apr.
2
Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients.带状疱疹:发生、并发症及复发的危险因素,重点关注免疫功能低下患者
Diseases. 2025 Feb 26;13(3):71. doi: 10.3390/diseases13030071.
3
The Incidence of Herpes Zoster Complications: A Systematic Literature Review.
带状疱疹并发症的发病率:一项系统文献综述。
Infect Dis Ther. 2024 Jul;13(7):1461-1486. doi: 10.1007/s40121-024-01002-4. Epub 2024 Jun 19.
4
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.亚太地区部分地区带状疱疹的流行病学和疾病负担的系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20.
5
Herpes Zoster Recurrence: A Narrative Review of the Literature.带状疱疹复发:文献综述
Dermatol Ther (Heidelb). 2024 Mar;14(3):569-592. doi: 10.1007/s13555-024-01101-7. Epub 2024 Feb 28.
6
Pharmacological Treatment of Herpes Zoster and Factors Associated with Its Recurrence.带状疱疹的药物治疗及其复发相关因素
Antibiotics (Basel). 2023 Apr 14;12(4):757. doi: 10.3390/antibiotics12040757.
7
Recurrent herpes zoster in a rheumatoid arthritis patient treated with tofacitinib: A case report and review of the literature.托法替布治疗类风湿关节炎患者出现复发性带状疱疹:一例报告及文献复习
World J Clin Cases. 2022 Aug 26;10(24):8703-8708. doi: 10.12998/wjcc.v10.i24.8703.
8
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment.接受托法替布治疗的类风湿关节炎或银屑病关节炎患者带状疱疹的临床管理
Rheumatol Ther. 2022 Feb;9(1):243-263. doi: 10.1007/s40744-021-00390-0. Epub 2021 Dec 6.
9
Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.成年基础疾病患者的带状疱疹负担:对2007 - 2018年德国索赔数据的分析
Dermatol Ther (Heidelb). 2021 Jun;11(3):1009-1026. doi: 10.1007/s13555-021-00535-7. Epub 2021 May 6.
10
The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence.免疫功能正常、未接种疫苗的≥50 岁成年人中带状疱疹的流行病学:发病率、并发症、住院治疗、死亡率和复发。
J Infect Dis. 2020 Aug 4;222(5):798-806. doi: 10.1093/infdis/jiz652.